logo

For the Inventor, By the Inventor

Rockville, MD, United States of America

Nabi Biopharmaceuticals, Inc.

Calculating rank
USPTO Granted Patents = 13

% Expired Patents = 61.5


Trademarks = 2

Forward Citations = 101

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal Ali Ibrahim Fattom (10 out of 27 patents)

silverMedal Sofiane Ennifar (6 out of 9 patents)

bronzeMedal Robert B Naso (6 out of 9 patents)

4.  Viliam Pavliak (3 out of 4 patents)

5.  Edmund V Dennett, Jr (1 out of 12 patents)

6.  Paul D Kessler (1 out of 10 patents)

7.  Robert M Raleigh (1 out of 3 patents)

8.  Matthew Hohenboken (1 out of 1 patent)

9.  Raafat Fahim (1 out of 1 patent)

10.  Leslie Hudson (1 out of 1 patent)

11.  Scott Winston (1 out of 1 patent)

12.  James Terrill (1 out of 1 patent)

13.  Steve Fuller (1 out of 1 patent)

14.  Ramesh K Sood (1 out of 3 patents)

15.  Sara E Shepherd (1 out of 2 patents)


13 patents:

1. 8232072 - Smoking cessation kit and method (2012-07-31),
2. 8026109 - Hapten-carrier conjugates for treating and preventing nicotine addiction (2011-09-27),
3. 7776620 - Hapten-carrier conjugates for treating and preventing nicotine addiction (2010-08-17),
4. 7547712 - Methods for decreasing the toxic effects of nicotine on fetuses in pregnant women (2009-06-16),
5. 7531633 - [object Object] (2009-05-12),
6. 7449189 - Glycoconjugate vaccines for use in immune-compromised populations (2008-11-11),
7. 7446205 - Method for making nicotine hapten (2008-11-04),
8. 7291343 - [object Object] (2007-11-06),
9. 7247502 - Hapten-carrier conjugates for treating and preventing nicotine addiction (2007-07-24),
10. 7030101 - Compositions of β-glucans and specific antibodies (2006-04-18),
11. 6936258 - Staphylococcus antigen and vaccine (2005-08-30),
12. 6875445 - Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption (2005-04-05),
13. 6773891 - Hapten-carrier conjugates for treating and preventing nicotine addiction (2004-08-10),
Company Overview
Nabi Biopharmaceuticals, Inc. is a biopharmaceutical company based in Rockville, Maryland, specializing in the development of innovative therapies for unmet medical needs. The organization focuses on advancing treatments in the fields of immunology and infectious diseases, leveraging its expertise in vaccine development and antibody therapies. With a commitment to improving patient outcomes, Nabi Biopharmaceuticals aims to address significant health challenges through its research and development initiatives.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

13 Patents

#52 in Rockville, MD

#331 in Maryland

#23,863 in US

#45,104 in the World

Rockville, MD (US)
Rockville, MD, United States of America

Nabi Biopharmaceuticals, Inc.

Forward Citations = 101

17 inventors:

goldMedal Ali Ibrahim Fattom (10 out of 27 patents)

silverMedal Sofiane Ennifar (6 out of 9 patents)

bronzeMedal Robert B Naso (6 out of 9 patents)

4.  Viliam Pavliak (3 out of 4 patents)

5.  Edmund V Dennett, Jr (1 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nabi Biopharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/nabi-biopharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…